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King Sau
osting by EAbstract A new, simple and low cost spectrophotometric method for the determination of meth-
yldopa in pharmaceutical preparations was developed. The method was based on the coupling of
methyldopa with 2,6-dichloroquinone-4-chlorimide (DCQ). The absorbance maximum (kmax) of
the resulted colored product was at 400 nm. Different buffers were used to determine the optimal
pH for the reaction. About 1% w/v acetate buffer with pH 8.0 gave the optimal pH required for
the reaction. Of the different solvents tried, water and ethanol were found to be the most suitable
solvents. Beer’s law was obeyed in concentration range of 4–20 lg/ml methyldopa. The correlation
coefﬁcient was found to be (r= 0.9975). The limit of detection and limit of quantiﬁcation were
1.1 lg/ml and 3.21 lg/ml, respectively. The reaction ratio between methyldopa and DCQ was stud-
ied and found to be 1:3. The work included the study of the possible interference of hydrochloro-
thiazide found in combination with methyldopa tablets. The method was validated and results
obtained for the assay of two different brands of methyldopa tablets were compared with the BP
method (colorimetric). The repeatability and reproducibility of the developed method were evalu-
ated and the obtained results quoted. The derivative formed as a result of the reaction of methyl-
dopa with DCQ was isolated and its possible mechanistic pathway was suggested.
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lsevier1. Introduction
Methyldopa is a catechol derivative (catecholamine)widely used
as antihypertensive agent. It is a centrally acting a-2-adrenocep-
tor agonist, which reduces sympathetic tone and produces a fall
in blood pressure (Gilman et al., 1996). The spectrum of activity
ofmethyldopa lies between those of themore potent agents, such
as guanethidine, and the milder antihypertensive, such as reser-
pine. Methyldopa is a structural analogue of dihydroxyphenyl
alanine (dopa); it differs only in the presence of methyl group
on the a-carbon of the side chain (Graig and Stitzel, 2003).
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either as S orR-isomer. The activity ofmethyldopa as antihyper-
tensive is due to the S-isomer of a-methyldopa.
Several types of analytical procedures have been reported
for the analysis of methyldopa in bulk form, pharmaceutical
form or biological ﬂuids. These include titrimetry (Amin,
1986), spectrophotometry (El-Rabbat and Omar, 1978; David-
son, 1984; Walash et al., 1985; Issopoulos, 1989; Ribeiro et al.,
2005; Krishan et al., 1990; Zivanovic et al., 1991; Babu et al.,
2001), and chromatography (Hjemdahl, 1984; Das Gupta and
Dhruv, 1986; Rosa et al., 1995; Benza et al., 1996). Further-
more, cyclic voltametry (Ali and Sami, 2005), electrochemical
oxidation and kinetic methods (James et al., 2006; Matthieu
et al., 2006) have been cited. DCQ was utilized for the spectro-
photometric determination of some sympathomimetic catechol
amines (Sankar et al., 1987; Rosano et al., 1991; Aly et al.,
1994; Bakry et al., 1997; Mohamed et al., 2002), the phenolic
drug, propofol (Gadkariem and Abounassif, 2000), thiol drugs
as penicillamine and captopril (Al-Majed, 1999; El-Enany
et al., 2007) and amines containing drugs as sodium ﬂoxacillin
and leﬂunomide (Refat and El-Didamony, 2006; Abbas et al.,
2006). This paper deals with the use of DCQ (Gibbs reagent) as
a chromogen for the spectrophotometric assay of methyldopa.
2. Experimental
2.1. Materials and equipment
Methyldopa reference material was obtained from Shinpoong
Pharm. Co. Ltd., Seoul, Korea, labeled to contain 88.65% w/
w anhyd. methyldopa. Pharmaceutical formulations containing
methyldopa were obtained locally from different sources. The
spectrophotometric measurement and the infra-red spectros-
copy study were done using Jasco V-530 UV/vis spectropho-
tometers, Japan and Shimadzu FTIR model 8400, Kyoto,
Japan, respectively. The chromogen reagent, 2,6-dichloroqui-
none-4-chlorimide (DCQ), was obtained from Merck, Darms-
tadt, Germany. The 0.125% w/v of the reagent was freshly
prepared in absolute ethanol. Dimethylsulfoxide (DMSO) ex-
tra pure was obtained from Scharlau Chemie, S.A., Spain.
All chemicals and solvents were either analytical grade or
general purpose reagents purchased from different sources.
2.2. Buffer solutions
Phosphate buffers of pH (3.0, 7.0, and 9.6) were prepared
according to BP (2005) The British Pharmacopoeia, 2007;
and sodium acetate buffer of pH 8.0 and strength of 1% w/v
was prepared in water.
2.3. Stock solution of standard methyldopa
A mass containing about 0.08 g of anhyd. methyldopa was
accurately weighed and transformed into a 100 ml volumetric
ﬂask, dissolved in water to 100 ml; then 1 ml of the resultant
solution was diluted to 10 ml with water to give a ﬁnal concen-
tration of 80 lg/ml.
2.4. Stock solution of methyldopa tablets
Twenty tablets were accurately weighed and powdered. A mass
containing an equivalent to 0.08 g of anhydrous methyldopawas accurately weighed and quantitatively transformed into
a 100 ml volumetric ﬂask. About 70 ml of water was added,
and the mixture was shaken for about 10 min. The volume
of the mixture was adjusted to 100 ml with water and ﬁltered.
Exactly 1 ml of the ﬁltrate was diluted to 10 ml with water to
give a nominal concentration of 80 lg/ml methyldopa.
3. Procedure
3.1. Calibration curve
Several dilutions were prepared from the standard methyldopa
stock solution. Aliquots of 0.5 ml, 1.0 ml, 1.5 ml, 2.0 ml and
2.5 ml of the stock solution were transformed to 10 ml-volu-
metric ﬂasks followed by addition of 2 ml, 1.5 ml, 1.0 ml,
0.5 ml and 0 ml water to the ﬁve 10 ml ﬂasks in order. Finally
1 ml of sodium acetate buffer and 1 ml of freshly prepared
DCQ were added to each ﬂask. The solutions were allowed
to stand for 1 h before their volumes were completed to
10 ml with water. A blank solution was prepared in the same
way using 2.5 ml water instead of 2.5 ml standard stock solu-
tion of methyldopa.
The absorbance of each solution was measured at 400 nm
against a blank. Linear regression analysis was performed
and the linear equation for the best ﬁtting line was calculated.
3.2. Assay of methyldopa tablets
To 1.5 ml of stock solution of methyldopa tablets, 1 ml of
water, 1 ml of sodium acetate buffer and 1 ml of freshly pre-
pared DCQ were added. The solution was allowed to stand
for 1 h before the completion of volume to 10 ml with water.
The concentration of the test solution can be computed from
the calculated linear equation and accordingly the content of
methyldopa per tablet can be worked out.
Alternatively the content of methyldopa per tablet can be
found out from the following adopted expression (Gadkariem
and Abounassif, 2000)
Content of methyldopa=tablet ¼ Asm  CDW1
Astd W2  105
where Asm = absorbance of sample solution (i.e. test solution);
Astd = absorbance of standard solution; C= concentration of
standard solution (lg/ml); D= dilution factor for the sample;
W1 = average weight of the tablet; W2 = weight of the pow-
dered tablet taken.
4. Results and discussion
Methyldopa exhibits weak UV-absorption in the range 250–
300 nm (kmax is 280 in water and the molar absorbitivity ‘‘e’’
is 2789.4). Therefore, a suitable chromogen is needed to react
with methyldopa to obtain a more light absorbing derivative
that can be useful for a sensitive spectrophotometric determi-
nation of methyldopa in bulk from, dosage form and, if possi-
ble, in biological ﬂuids.
Methyldopa has a catechol moiety (3,4-dihydroxyphenyl)
and DCQ is known to react with phenolic compounds in alka-
line media to give indophenols (colored species) (Pesez and
Bartos, 1974). Based on this reported reaction we investigated
the behavior of DCQ when allowed to react with methyldopa
Figure 1 UV/vis spectrum of the reaction product and the DCQ
blank using water as solvent (pH 8.0, conc. 16 lg/ml).
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tion, intensity and stability. These factors include diluting sol-
vent, the reagent concentration and volume, the reaction time,
alkalinizing agent and temperature. Different diluting solvents
with differrent dielectric constants (DE), namely water (DE
80), ethanol (DE 24.6), acetonitrile (DE 37.5), and DMSO
(DE 46.7), and different alkalinizing agents, namely phosphate
buffer of pH 3.7 and 9.6 and 1% w/v sodium acetate solution
pH 8 were used. The reagent DCQ at a preliminary concentra-
tion of 0.25% w/v in ethanol at volume 1 ml was used to study
the color formation with these solvents and buffers. The color
was observed to develop well with all these solvents and buf-
fers at different rates. UV–vis scanning between 300–750 nm
of the developed color for each solution revealed the presence
of two peaks at about 400 nm and at about 670 nm suggesting
possible p–p* and n–p* transitions. Using water as the diluting
solvent. The colored product was having an analytically useful
maximum at 400 nm (possibly p–p* transition) and a weak
rather ﬂat peak at about 670 nm (possibly n–p* transition).
A similar pattern of spectra was obtained when using ethanol
as diluting solvent; however both peaks at 400 nm and 670 nm
were clear and of deﬁnite shape and maxima. For acetonitrile,
the peak at 670 nm was of higher intensity than the peak at
400 nm which was weak and rather ﬂat. However the peak
at 670 nm was of limited range of sensitivity (0.1–0.6 lg/ml,
r= 0.97) and poor reproducibility. Solution diluted with
DMSO also gave a high intensity peak at about 670 nm which
was not consistent (wavelength shift between 635 and 670 nm)
and a weak one at 400 nm. The blank solution in the case of
DMSO tends to increase quickly and negative absorption val-
ues for the colored product at low concentrations were ob-
tained. It is known that polar solvents enhance p–p*
transition and non-polar solvents enhance n–p* transition.
This is due to stabilization of the ground state through hydro-
gen bonding (Williams and Fleming, 1980). Thus these ﬁndings
are in agreement with this statement. The inﬂuence of pH on
the absorption value of the reaction product was evaluated
using the above mentioned buffers. Maximum color intensity
was obtained using 1% w/v sodium acetate (pH 8). Other buf-
fers were either giving less sensitivity response or distorted
undeﬁned peak with high blank reading.
Attempts to accelerate the reaction by heating at different
temperatures was not successful as inconsistent readings were
obtained and even negative absorption values were obtained
due to high colored blank and shifts in wavelength maxima.
To optimize the concentration and volume of the reagent
0.5 ml, 1.0 ml and 1.5 ml of the 0.25% w/v DCQ in ethanol
were used for color development using water or ethanol as
diluting solvents and 20 lg/ml solution of the methyldopa ref-
erence material. Absorption values of less than 3% variation
were obtained for the different volumes. Therefore a volume
of 1 ml of 0.125% w/v DCQ in ethanol was used for accurate
reproducible volume use.
It was found that, the sequence of reagents addition, the
diluting solvent and one hour waiting time were necessary
for maximum color development. Either water or ethanol
could be used as a diluting solvent; although ethanol gave a
higher color intensity about 1.3 times that obtained with water;
however, water being readily available, of less cost and haz-
ards, is therefore analytically preferred. Fig. 1 shows a typical
absorption spectra of methyldopa–DCQ derivative diluted
with water overlaid with DCQ blank spectrum. The formedcolor was stable for at least two hours showing variations of
less than ±2% absorption readings for a 16 lg/ml solution.
Under these conditions calibration graphs were constructed
using a reference sample of methyldopa. The graphs were lin-
ear with drug concentrations range 4–20 lg/ml and 3–15 lg/ml
for the water and the ethanol solutions respectively.
Data for linearity of the reaction and the spectral data using
water and ethanol are assembled in Table 1.
The accuracy of the procedure and freedom from interfer-
ence by the tablet excipients were checked by recovery testing
of added amounts of the reference drug to sample solutions in
the ratio 1:1. The results showed a good recovery (101.7%)
with a low RSD (±0.84%).
The repeatability of the method was investigated using
16 lg/ml – reference solution; the result obtained was
100.0 ± 1.7%. The reproducibility of the method was studied
using 8 lg/ml, 12 lg/ml and 16 lg/ml reference solutions
(n= 3); the results obtained were 102.2 ± 1.96, 101.88 ±
1.64 and 101.1 ± 1.8 for these solutions respectively. These
results represent the accuracy and precision of the method.
Table 2 shows the results obtained for two brands of meth-
yldopa tablets collected from local pharmacies using the devel-
oped method compared to the BP method.
The observed t-test and F-ratio values as compared to the
corresponding tabulated values at 95% conﬁdence level indi-
cated that the calculated t-values and F-ratios are less than
the tabulated ones; suggesting that there were no signiﬁcant
differences between the proposed method and the B.P method
with regard to accuracy and precision (Miller and Miller,
2005).
Table 1 Linear regression data for methyldopa–DCQ reaction.
Solvent kmax
(nm)
Linearity range
(lg/ml)
Intercept ± SD Slope ± SD Correlation
coeﬃcient (r)
Molar absorptivity
(L mol1 cm1)
Water 400 4–20 0.035 ± 0.011 0.0339 ± 0.01 0.997 6.42 · 103
Ethanol 400 3–15 0.071 ± 0.0134 0.0469 ± 0.01 0.998 8.32 · 103
Scheme 1 Proposed reaction pathway between DCQ and
methyldopa.
Figure 2 UV/vis spectrum of the reaction product using ethanol
as solvent (pH 8.0, conc. 4 lg/ml).
Table 2 Content (%) of methyldopa± SD in tablets using proposed method compared to the BP method.
The developed method BP method tcal (tab)* Fcal (tab)*
Brand (1) 101.91 ± 1.82
n= 6
99.90 ± 1.44
n= 6
2.12 (2.78) 1.60 (19.00)
Brand (2) 101.44 ± 0.96
n= 3
101.62 ± 0.24
n= 3
0.33 (2.78) 16.61 (19.00)
n= number of replicates; * = tab at 95% conﬁdence level.
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(LOQ) for methyldopa using the proposed method were found
to be 1.1 lg/ml and 3.21 lg/ml, respectively. The statistical cal-
culation of these limits was performed using the following
equation (Guidance for Industry, 2001):
LOD ¼ 3:3 d=S and LOQ ¼ 10 d=S
where d= standard deviation of the intercept of the regression
line; S= the slope of the calibration line.
No signiﬁcant interference was observed due to the
coexisting hydrochlorothiazide which is coformulated with
methyldopa at the ratios 1:16 or 1:10 (hydrochlorthiaz-ide:methyldopa). Investigation of the stoichiometry of the
reaction using Job’s method, molar ratio method and the slope
ratio method revealed a 1:3 ratio (1 mol methyldopa:3 mol
DCQ). Furthermore, the derivative was prepared according
to the procedure described in the experimental part and iso-
lated. A KBr-disc was made and the recorded IR-spectrum
of the derivative, was compared with the IR-spectra of pure
methyldopa, and pure DCQ.
A possible scheme for the reaction and structure of the
formed derivative is shown in Scheme 1. Although the IR-spec-
trum of the derivative supports the proposed mechanism, no
deﬁnite conclusion for the structure could be drawn. Further
studies involving nuclear magnetic resonance, mass spectrom-
etry and elemental analysis are therefore recommended.
The structure was proposed based on the disappearance
of phenolic-OH stretch at about 3630 cm1, disappearance of
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indicates the presence of carbonyls of ketones and carboxylates
and C‚N, presence of peaks at 800–600 cm1 indicates the
presence of C–CL stretch, and the presence of NH stretch
at about 3140 cm1 and N–H bend at 1540 cm1.
Of interest was the observation that the derivative showed
in ethanol two peaks at 400 nm (major) and at 670 nm (minor)
Fig. 2. Beer’s law was obeyed at the two wavelengths. Based on
this ﬁnding, the absorption ratio A400/A670 was found to be
1.9 ± 0.1, n= 5. It is therefore possible to use this value of
the absorption ratio as an identiﬁcation test for methyldopa.
Unlike the developed method, most of the reported meth-
ods for the assay of methyldopa require expensive or sophisti-
cated instruments or involve procedures with rigorous control
of experimental conditions. Therefore, it can be concluded that
the developed method is suitable for routine analysis of meth-
yldopa. Furthermore, the method is not susceptible to the
interference by the coformulated hydrochlorothiazide.References
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